The founder of an Oban-based marine biotechnology company – whose groundbreaking work could lead to a cure for MRSA – has been officially recognised as one of the top entrepreneurs in Britain.
Dr Andrew Mearns Spragg, chief executive officer of Aquapharm Biodiscovery Limited, was one of the five regional finalist candidates, in the science and technology sector, to win a place in the national finals of the Ernst & Young Entrepreneur of the Year awards.
The 36-year-old businessman, who recently won the title of Ernst & Young Scottish Entrepreneur of the Year in health care, fought off tough competition to reach the UK finals, which were held in London on October 6.
The milestone recognised his entrepreneurial ambition in setting up Aquapharm, as well as his pioneering and innovative work in developing new antibiotic compounds derived from the marine microbial environment.
Aquapharm, which to date has raised more than